BLACKROCK NORTH AMERICAN INCOME TRUST plc
All information is at 31 May 2013 and unaudited.
Performance at month end with net income reinvested
One month Since launch
(24 Oct 2012)
Net asset value +3.0% +18.0%
Share price +3.2% +19.1%
Russell 1000 Value Index +5.3% +25.5%
Source: BlackRock
At month end
Net asset value - capital only: 113.43p
Net asset value - cum income: 113.85p
Share price: 117.00p
Premium to cum income NAV: 2.8%
Net yield*: 1.7%
Total assets including current year revenue: £87.23m
Target yield**: 4.0%
Gearing: 0.6%
Options overwrite: 17.7%
Ordinary shares in issue: 76,175,000
The Company did not issue any shares during the month.
*based on dividends of 1p per share each declared on 14 February 2013 and
14 May 2013
** based on issue price of 100p
Benchmark
Sector Analysis Total Assets (%)
Financials 21.4
Energy 14.2
Industrials 13.1
Consumer Staples 13.0
Consumer Discretionary 9.6
Health Care 9.1
Materials 6.6
Utilities 6.5
Information Technology 4.8
Telecommunication Services 3.6
Net current liabilities -1.9
-----
100.0
=====
Country Analysis Total Assets (%)
USA 92.0
Canada 3.7
Australia 1.7
Netherlands 1.5
France 1.4
United Kingdom 1.3
Peru 0.3
Net current liabilities -1.9
-----
100.0
=====
Ten Largest Investments(in alphabetical order)
Company Country of Risk
Ace USA
Chevron USA
Comcast USA
Exxon Mobil USA
General Electric USA
Home Depot USA
JPMorgan Chase USA
Merck USA
Pfizer USA
Wells Fargo USA
Bob Shearer and Kathleen Anderson, representing the Investment Manager, noted:
Performance
For the one month period ended 31 May 2013, the Company posted a 3.0% increase
in its NAV while the share price increased by 3.2% (all in sterling with dividends
reinvested). The Company's benchmark, the Russell 1000 Value Index, returned 5.3%.
On a relative basis, the largest contributor to the Company's performance
during the period was an overweight to the industrials sector. Stock selection
in the utilities sector also boosted relative returns, as did an underweight to
health care and an overweight to consumer discretionary.
A combination of stock selection and an overweight to consumer staples was the
largest detractor from relative performance during the period. Negative stock
selection in the energy, consumer discretionary and information technology
sectors also hurt relative returns, as did stock selection in the industrials
and materials sectors. Lastly, an underweight to financials also detracted from
relative performance for the month.
Positioning
As of 31 May 2013, the Company's options exposure was 17.7% and the delta of
the options was 93.2%.
During the month, we reduced our relative underweight to the financials sector
by putting excess cash to work in Citigroup, SunTrust Banks and JPMorgan Chase.
We also reduced our underweight to health care by adding to our position in
Johnson & Johnson. The Company is currently overweight to the consumer staples,
industrials, materials, consumer discretionary and telecommunication services
sectors. We have a neutral weighting in utilities and remain underweight to the
financials, health care, information technology and energy sectors.
ENDS
18 June 2013
Latest information is available by typing www.brna.co.uk on the internet,
"BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.